Skip to content
Recall Observatory FDA recall evidence

Drug product

Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only, Manufactured by: Houns Co., Ltd, 100, Bio valley, Je-cheor-Si, Chungcheongbuk-dc, Korea, NDC 73293-0002-1 (2 mL ampule), NDC 73293-0002-2 (50 x 2 Single-dose ampules); Distributed: Brookfield Pharmaceuticals, LLC, Brookfield, WI 53005, Made in S. Korea, NDC 71351-022-02 (ampule), NDC 71351-022-10 (10 count ampules), NDC 71351-022-50 (50 count ampules)

D-0530-2026

April 02, 2026

Class II

Product summary

Firm
Huons Co., Ltd.
Event
Event 98724
Status
Ongoing
Classification
Class II
Quantity
3,260,170 ampules
Official record key
drug-enforcement:D-0530-2026

Official wording

Reason: Lack of Assurance of Sterility

Code information: All lots within expiry

Distribution pattern: USA Nationwide.

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility